The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation
Key facts
- Who runs it
- Umraniye Education and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 2 people enrolled
- Started
- 1 Dec 2025
- Ended
- 30 May 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Edmonton frailty scale calculation
- Record updated
- 8 October 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- pediatric patients
Who cannot take part
- pregnant patients
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study was to determine the independent association of frailty with cardiopulmonary resuscitation and predictive factors in patients triggering code blue response
The 2 groups in the trial
- Edmonton frailty scale ≥ 7
The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile
Treatment: Edmonton frailty scale calculation
- Edmonton frailty scale below 7
The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile
Treatment: Edmonton frailty scale calculation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 October 2026